[{"NetIncomeLoss_1_Q1_USD":-15749000.0,"Liabilities_0_Q1_USD":421119000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-21000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":5995000.0,"MarketableSecuritiesCurrent_0_Q1_USD":0.0,"RecoveryOfDirectCosts_1_Q1_USD":14300000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":46981016.0,"AccruedLiabilitiesCurrent_0_Q1_USD":70452000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3221000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":2698000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":23240000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q1_USD":200000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":194684000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":34097000.0,"InterestPaidNet_1_Q1_USD":4936000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":114124000.0,"OtherAssetsNoncurrent_0_Q1_USD":520000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-2143000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q1_USD":3925000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":31440000.0,"RepaymentsOfConvertibleDebt_1_Q1_USD":108568000.0,"PrepaidExpenseCurrent_0_Q1_USD":14291000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":10693000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":1960000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-1000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-19000.0,"CommonStockValue_0_Q1_USD":5000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_security":0.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":7465000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":251000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":18561000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":114100000.0,"OtherAssetsCurrent_0_Q1_USD":29967000.0,"IncreaseDecreaseInInventories_1_Q1_USD":256000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-15770000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":3764000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":23240000.0,"CommonStockSharesIssued_0_Q1_shares":47241098.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":1290000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":122687000.0,"CommonStockSharesOutstanding_0_Q1_shares":47241098.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5410000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-19113000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":5442000.0,"LiabilitiesCurrent_0_Q1_USD":80399000.0,"AccountsPayableCurrent_0_Q1_USD":7782000.0,"InterestExpense_1_Q1_USD":4364000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":114691000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":678000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":114124000.0,"AdditionalPaidInCapital_0_Q1_USD":1097539000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":678000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":5585000.0,"OperatingLeasePayments_1_Q1_USD":0.0,"ReceivablesNetCurrent_0_Q1_USD":26305000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":745000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":22688000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1313554000.0,"RestrictedCashEquivalentsCurrent_0_Q1_USD":567000.0,"Assets_0_Q1_USD":205109000.0,"SecuredDebt_0_Q1_USD":147640000.0,"ShareBasedCompensation_1_Q1_USD":5410000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3575000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1012000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":56261000.0,"OperatingIncomeLoss_1_Q1_USD":-13401000.0,"InventoryNet_0_Q1_USD":9430000.0,"InvestmentIncomeInterest_1_Q1_USD":57000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":205109000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2165000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.34,"StockholdersEquity_0_Q1_USD":-216010000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":358000.0,"ConvertibleDebt_0_Q1_USD":189859000.0,"Ticker":"RDUS","CIK":"1428522","name":"RADIUS HEALTH, INC.","OfficialName":"Radius Health Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"368163999.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]